DUK slips as analysts trim targets and options hedge up

Short interest is too small to drive the narrative here, but its direction is worth noting. At 2.0% of the free float, shorts are modest in absolute terms. The position has grown roughly 9% over the past month, edging from about 14 million shares to 15.6 million — a gradual, steady rebuild rather than a conviction short. Borrow remains cheap at 0.51% annualised, and availability is vast at over 2,600% of current short interest, meaning there is no lending market friction whatsoever. Positioning looks cautious rather than crowded.

The analyst picture tells the clearer story. The recent drift in targets reflects a sector repricing around higher-for-longer rates. JP Morgan lowered its target to $136 from $139 in mid-May while keeping a Neutral rating. Truist followed days later, cutting from $142 to $137 while maintaining Buy. Those moves follow earlier action from Morgan Stanley in April, which trimmed to $141. The consensus mean target has settled around $138.60 — still 14% above where the stock is trading — but the direction of travel for individual targets has been mostly lower since April's more optimistic revisions. DUK's analyst recommendation divergence ranks in the 92nd percentile of the universe, meaning the Street remains notably more constructive than where the price sits. EPS surprise history ranks in the 72nd percentile, indicating DUK has a solid record of beating estimates.

Valuation has compressed with the price. The P/E multiple has shed just over one full turn in the past 30 days to 17.6x, and the price-to-book has eased to 1.63x — both declining as the stock drifted without a fundamental trigger. The EV/EBITDA at 10.7x has actually ticked up slightly week-on-week. Bulls point to capex upside from the updated Carolinas Resource Plan and management's guidance for above-6.5% annualised EPS growth, supported by roughly 2% population growth in its core Carolinas, Florida, and Indiana territories. Bears counter that dividend growth running at approximately 2% per year lags the sector average of around 5.5% — a meaningful disadvantage when competing for yield-sensitive capital. The ORTEX short score of 35.4 is benign, sitting near the middle of the universe and consistent with a stock that attracts no real negative conviction from the borrowing market.

Insider flow from the past month adds mild colour. CEO Harry Sideris sold 20,000 shares on May 8 at $124.37, collecting just under $2.5 million — the largest single insider transaction in the recent window. A divisional CEO sold a further 3,500 shares three days later. Both sales occurred at prices above where the stock trades now, which partly explains the week's drift. Net insider flow over 90 days runs modestly negative in share terms, with the sells concentrated in the $124–$131 range.

The next formal earnings catalyst lands August 6. What to watch between now and then is whether the sector's rate-sensitivity narrative intensifies further — or whether incoming macro data eases pressure on utility multiples enough to let DUK's 14% analyst return potential gap start closing.